Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Biotek-snakken
  4. Biotek-snakken — November 2021

Biotek-snakken — November 2021

Planlagt Fastgjort Låst Flyttet Biotek-snakken
250 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • restenR Offline
    restenR Offline
    resten
    wrote on sidst redigeret af
    #15

    Så vinder Teva i Californien

    1 Reply Last reply
    0
    • restenR Offline
      restenR Offline
      resten
      wrote on sidst redigeret af
      #16

      https://sdfe.dk/data-skaber-vaerdi/nyheder/nyhedsarkiv/2021/nov/nu-kan-du-faa-adgang-til-mange-tusinde-historiske-kort?fbclid=IwAR0_SgGCCa9E91kElSnShKGfOPhus772LEwvmk18Y1cpGDFDmOrxEf6MLMg

      1 Reply Last reply
      0
      • L Offline
        L Offline
        lahn1
        wrote on sidst redigeret af
        #17

        Styrelsen for Dataforsyning og Effektivisering ?

        1 Reply Last reply
        0
        • restenR Offline
          restenR Offline
          resten
          wrote on sidst redigeret af
          #18

          Sorry 😉 https://www.reuters.com/world/us/california-judge-rules-drugmakers-major-opioid-lawsuit-2021-11-02/?fbclid=IwAR2xHGJHLHNgUmfm_VLUqmpbBmwlZJB3rdflbKW1F9WR-8gHwFrLFyu8zgc

          1 Reply Last reply
          0
          • S Offline
            S Offline
            Sukkeralf
            wrote on sidst redigeret af
            #19

            Merck satser yderligere på cytokines:

            1 Reply Last reply
            0
            • S Offline
              S Offline
              Sukkeralf
              wrote on sidst redigeret af
              #20

              https://endpts.com/merck-adds-another-cancer-and-autoimmunity-partner-as-deal-spree-continues/

              1 Reply Last reply
              0
              • M Offline
                M Offline
                Mcjean
                wrote on sidst redigeret af
                #21

                Hvorfor er Halo underdrejet, burde den ikke stige inden regnskab i nat? Indtjeningen må vel stige en del men måske ikke nok, den er godt nok kedelig.

                1 Reply Last reply
                0
                • Helge_LarsenPI-redaktørH Offline
                  Helge_LarsenPI-redaktørH Offline
                  Helge_LarsenPI-redaktør
                  wrote on sidst redigeret af
                  #22

                  4 Top Health Care Stocks For Your
                  November 2021 Watchlist https://www.proinvestor.com/investornyt/728166/4-top-health-care-stocks-for-your-november-2021-watchlist

                  1 Reply Last reply
                  0
                  • SolsenS Offline
                    SolsenS Offline
                    Solsen
                    wrote on sidst redigeret af
                    #23

                    Jeg har aldrig helt fundet ud af hvad deres patentudløb betyder for deres indtjening. Men tror der ligger noget her der begrænser festen i HALO, Men i disse kursniveauer ville jeg ikke være bange 😉

                    1 Reply Last reply
                    0
                    • M Offline
                      M Offline
                      Mcjean
                      wrote on sidst redigeret af
                      #24

                      Men hvorfor faldt den så meget?

                      1 Reply Last reply
                      0
                      • M Offline
                        M Offline
                        Mcjean
                        wrote on sidst redigeret af
                        #25

                        Når men du tager vel præsentationen kl.01.30 og laver et fyldigt resume:-)

                        1 Reply Last reply
                        0
                        • B Offline
                          B Offline
                          BioShare
                          wrote on sidst redigeret af
                          #26

                          Halo satte sig da salgsforventninger, efter nogens opfattelse, ikke blev opnået. Det er en lille guldklump med et fint kurspotentiale. 🙂

                          1 Reply Last reply
                          0
                          • B Offline
                            B Offline
                            BioShare
                            wrote on sidst redigeret af
                            #27

                            Halo - fint Q3 resultat, og 5% stigning after hours. https://finance.yahoo.com/news/halozyme-reports-third-quarter-2021-200100682.html

                            1 Reply Last reply
                            0
                            • M Offline
                              M Offline
                              Mcjean
                              wrote on sidst redigeret af
                              #28

                              Burde stige 30%

                              1 Reply Last reply
                              0
                              • M Offline
                                M Offline
                                Mcjean
                                wrote on sidst redigeret af
                                #29

                                men stiger nok op til årsregnskab.

                                1 Reply Last reply
                                0
                                • SolsenS Offline
                                  SolsenS Offline
                                  Solsen
                                  wrote on sidst redigeret af
                                  #30

                                  U.S. patent which expires in 2027 and an issued European patent which expires in 2024, which we believe cover the products and product candidates under our existing collaborations, and Hylenex. Although we believe our patent filings represent a barrier to entry for potential competitors looking to utilize these hyaluronidases, upon expiration of our patents other pharmaceutical companies may (if they do not infringe our other patents) seek to compete with us by developing, manufacturing and sell

                                  1 Reply Last reply
                                  0
                                  • SolsenS Offline
                                    SolsenS Offline
                                    Solsen
                                    wrote on sidst redigeret af
                                    #31

                                    and selling biosimilars to the active drug ingredient in our ENHANZE technology used by our collaboration partners in combination with their products. Any such loss of patent protection or proprietary rights could lead to a reduction or loss of revenues, incentivize one or more of our key ENHANZE collaboration partners to terminate their relationship with us and impact our ability to enter into new collaboration and license agreements.

                                    1 Reply Last reply
                                    0
                                    • SolsenS Offline
                                      SolsenS Offline
                                      Solsen
                                      wrote on sidst redigeret af
                                      #32

                                      Tror at hunden ligger begravet her….

                                      1 Reply Last reply
                                      0
                                      • SolsenS Offline
                                        SolsenS Offline
                                        Solsen
                                        wrote on sidst redigeret af
                                        #33

                                        Har lyttet til nogle webcasts hvor de er spurgt ind til dette afsnit i deres 10Q. Men jeg er aldrig blevet helt klog på det.

                                        1 Reply Last reply
                                        0
                                        • SolsenS Offline
                                          SolsenS Offline
                                          Solsen
                                          wrote on sidst redigeret af
                                          #34

                                          Jeg sidder ikke oppe i nat solgte ud for længe siden grundet jeg ikke har klar besked på deres fremtidige muligheder for at holde aftalerne kørende.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper